Author(s)

Paola Atallah^1*, Mohamed El-Zaheri^2*, Omar Abu-Hijleh², Emile Andari³, Fares Haddad⁴, Hiba Hajar⁵, Kamal Hirbli⁶, Nadim Jarrah⁷, Rita Medlej⁸, Charles Saab⁹

¹Department of Endocrinology, Saint George Hospital University Medical Center, Beirut, Lebanon.
²Department of Endocrinology, Jordan Hospital Medical Center, Amman, Jordan.
³Endocrinology Department, Notre Dame de Secours Hospital, Byblos, Lebanon.
⁴Department of Endocrinology, King Hussein Medical Center, Amman, Jordan.
⁵Medical Department, AstraZeneca Near East, Beirut, Lebanon.
⁶Endocrinology Department, Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon.
⁷Department of Endocrinology, Specialty Hospital, Shmeisani, Amman, Jordan.
⁸Department of Endocrinology, Hotel Dieu de France Hospital, Beirut, Lebanon.
⁹Department of Endocrinology and Metabolic Diseases, Sacré Coeur Hospital, Beirut, Lebanon.

Introduction: Type 2 Diabetes Mellitus (T2DM) has witnessed a rise in its prevalence worldwide and in the Middle East region. The overall burden associated with the disease is well characterized, but little is known about patient satisfaction in the region. The purpose of the study is to evaluate the quality of life (QoL) and treatment satisfaction of patients T2DM. Methods: The SIMPLIFY study was an observational, cross-sectional, multicenter, regional study that used patient-reported outcomes of T2DM patients in Jordan and Lebanon. Results: Patients were more satisfied when they were treated exclusively with oral medications, mainly metformin alone or combined with either sulfonylurea or dipeptidyl peptidase-4 inhibitor. Targets for glycated hemoglobin (HbA1c) values were better reached in patients treated with oral medications. Occurrence of comorbidities did not seem to be affected by oral or injectable medications or to affect patients’ satisfaction. Data highlighted a suboptimal screening for albuminuria and showed that most patients were overweight or obese and around 30% suffered from hypoglycemia episodes. Conclusion: Data shed the light on the management of T2DM in Jordan and Lebanon and suggested the need for a more comprehensive approach to T2DM management and selection of medications that would support weight control and a lower hypoglycemia incidence.

Diabetes, Glycated Hemoglobin, Clinical Management, Patient Satisfaction, Quality of Life

Atallah, P. , El-Zaheri, M. , Abu-Hijleh, O. , Andari, E. , Haddad, F. , Hajar, H. , Hirbli, K. , Jarrah, N. , Medlej, R. and Saab, C. (2020) Diabetes Management, Quality of Life and Treatment Satisfaction in Adult Population in Jordan and Lebanon, Observations from the SIMPLIFY Study. Journal of Diabetes Mellitus, 10, 73-87. doi: 10.4236/jdm.2020.102007.